 FARMINGDALE, N.Y., Dec. 18, 2020 GLOBE NEWSWIRE -- 2020 Misonix, Inc. NASDAQ: MSON, a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that the second largest U.S. Commercial payer will now cover Thera S kin for all lower extremity dermal wounds. TheraSkin is a proven cellular and tissue-based treatment for difficult to heal chronic wounds. 